Curriculum Vitae

Eva Trevisson was born in Dolo (Ve) 18th March 1978

She obtained her Medical Degree at the University of Padova and certification in Medical Genetics at the University of Siena. She earned her PhD in Rare Diseases (PhD School in Developmental Medicine, University of Padova). During her PhD program, supervised by Prof. Salviati, she set up models of neurometabolic conditions (mainly mitochondrial disorders and urea cycle defects).

She had also the opportunity to visit as fellow an excellent center of developmental biology in Spain (Centro Andaluz de Biologia del Desarrollo, Seville) in the Lab. of Prof. Navas, where she could work with C.elegans, that has been widely used in most research fields and she established a knockdown model of a mitochondrial disorder.

Since March 2011 she works as Assistant Professor of Medical Genetics at the Department of Women’s and Children’s Health of the University of Padova and since 2014 she leads a group in the laboratory of Genetics at the Istituto di Ricerca Pediatrica (IRP), where she is following on with modeling human genetic diseases in C.elegans and D.rerio and she has started a novel research line on cancer genetics.

Being a medical geneticist, she also performs genetic consultations at the Clinical Genetics Unit of the University Hospital of Padova, where she is in charge with the neurofibromatosis outpatient clinic. This clinical practice gave her the opportunity to deal with inherited tumor predisposing syndromes.

She teaches Molecular Genetics and Medical Genetics in different academic courses, medical residency programs and in the PhD program in neurosciences at the University of Padova. She is now supervising the PhD student Valeria Morbidoni.

She has co-authored 56 Medline publications and three chapters of book, with a total impact factor of 231 (Journal of Citation reports 2016), H-index 20, total citations 1507 (Scopus 2017).



Latest pubblications: Click here

Related Laboratories

Model organisms and rare diseases

The main interest of our laboratory has been the development of models to study the genetic bases and the pathophysiology of inherited neurometabolic disorders.